Low-dose Primaquine study

Low-dose Primaquine study

Objectives

Determining a safe and maximally efficacious dosing range of primaquine in combination with standard weight-based dosing of Dihydroartemisinin-piperaquine against Plasmodium falciparum gametocytes in G6PD normal and deficient patients with uncomplicated malaria

PI Institution(s)

Principal Investigator (PI)

Funding source(s)

Partner(s)

Key facts

  • Dates
    2014 to 2015
    Funding information
    Supported through core funding from BMGF and from CDC
    Country
    • Kenya

MESA tags

  • Methodology
    Operational research, Product development & clinical research
    Theme(s)
    Tools for elimination, Drug-based strategies